Literature DB >> 18781826

Raf kinase inhibitory protein (RKIP): a physiological regulator and future therapeutic target.

Lingchun Zeng1, Akira Imamoto, Marsha Rich Rosner.   

Abstract

BACKGROUND: Raf kinase inhibitory protein (RKIP) belongs to the phosphatidylethanolamine binding protein (PEBP) family that is expressed in both prokaryotic and euakaryotic organisms.
OBJECTIVE: In this review, we discuss the role of RKIP as a modulator of signal transduction, the relationship of RKIP to other members of the PEBP family, and the role of RKIP in human health and disease. RESULTS/
CONCLUSION: In mammals, RKIP regulates activation of MAPK, NF-kappaB and G protein coupled receptors (GPCRs). As a modulator of key signaling pathways, RKIP affects various cellular processes including cell differentiation, the cell cycle, apoptosis and cell migration. Emerging evidence suggests that RKIP is implicated in several human diseases or disorders, among them metastatic tumorigenesis and Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18781826     DOI: 10.1517/14728222.12.10.1275

Source DB:  PubMed          Journal:  Expert Opin Ther Targets        ISSN: 1472-8222            Impact factor:   6.797


  52 in total

1.  Proteomic analysis reveals molecular biological details in varioliform gastritis without Helicobacter pylori infection.

Authors:  Lin Zhang; Yan-Hong Hou; Kai Wu; Jun-Shan Zhai; Nan Lin
Journal:  World J Gastroenterol       Date:  2010-08-07       Impact factor: 5.742

Review 2.  The genetic basis of flowering responses to seasonal cues.

Authors:  Fernando Andrés; George Coupland
Journal:  Nat Rev Genet       Date:  2012-09       Impact factor: 53.242

3.  Rituximab-mediated Raf kinase inhibitor protein induction modulates NF-κB in Sjögren syndrome.

Authors:  Margherita Sisto; Sabrina Lisi; Massimo D'Amore; Dario D Lofrumento
Journal:  Immunology       Date:  2014-09       Impact factor: 7.397

4.  RKIP regulates MAP kinase signaling in cells with defective B-Raf activity.

Authors:  Lingchun Zeng; Karin Ehrenreiter; Jyotsana Menon; Ray Menard; Florian Kern; Yoko Nakazawa; Elena Bevilacqua; Akira Imamoto; Manuela Baccarini; Marsha Rich Rosner
Journal:  Cell Signal       Date:  2013-02-14       Impact factor: 4.315

5.  SSPaQ: A Subtractive Segmentation Approach for the Exhaustive Parallel Quantification of the Extent of Protein Modification at Every Possible Site.

Authors:  Guillaume Gabant; Alain Boyer; Martine Cadene
Journal:  J Am Soc Mass Spectrom       Date:  2016-05-31       Impact factor: 3.109

6.  RKIP and TBK1 form a positive feedback loop to promote type I interferon production in innate immunity.

Authors:  Meidi Gu; Zhiyong Liu; Rongrong Lai; Si Liu; Wenlong Lin; Chuan Ouyang; Sheng Ye; He Huang; Xiaojian Wang
Journal:  EMBO J       Date:  2016-10-17       Impact factor: 11.598

7.  Phosphatidylenthanolamine Binding Protein aka Raf Kinase Inhibitor Protein: A Brief History of Its Discovery and the Remarkable Diversity of Biological Functions.

Authors:  John M Sedivy
Journal:  For Immunopathol Dis Therap       Date:  2011

8.  Microenvironmental Influences on Metastasis Suppressor Expression and Function during a Metastatic Cell's Journey.

Authors:  Wen Liu; Carolyn J Vivian; Amanda E Brinker; Kelsey R Hampton; Evi Lianidou; Danny R Welch
Journal:  Cancer Microenviron       Date:  2014-06-18

9.  Characterization of the Raf kinase inhibitory protein (RKIP) binding pocket: NMR-based screening identifies small-molecule ligands.

Authors:  Anne N Shemon; Gary L Heil; Alexey E Granovsky; Mathew M Clark; Dan McElheny; Alexander Chimon; Marsha R Rosner; Shohei Koide
Journal:  PLoS One       Date:  2010-05-05       Impact factor: 3.240

10.  Effects of Raf kinase inhibitor protein expression on pancreatic cancer cell growth and motility: an in vivo and in vitro study.

Authors:  Haisu Dai; Haowei Chen; Wei Liu; Yu You; Jiaxin Tan; Aigang Yang; Xiangdong Lai; Ping Bie
Journal:  J Cancer Res Clin Oncol       Date:  2016-07-21       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.